Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the possible effect on central sensitization and allodynia is still unknown.
Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity o...
Migraine is a common primary headache disease, which reduces quality of life. About 8% of migraineur...
Recent trials have demonstrated that onabotulinumtoxinA is a safe and effective treatment for the pr...
Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the possible eff...
Background: Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the ...
Chronic migraine (CM) is a severely disabling neurological condition characterized by episodes of pu...
Migraine is a highly prevalent and disabling disorder accounted among the primary headaches. It is t...
Cephalic allodynia (CA) can be observed in 50-70% of patients with chronic migraine (CM). The aim of...
Chronic migraine is a debilitating headache, whose treatment is often complicated by the concomitant...
Recent studies demonstrating the effectiveness of botulinum toxin type A (BT-a) in treating several ...
Abstract: Objective : The Botulinum toxin A (BoNT/A), increasingly used in many fields in recent yea...
Texto completo: acesso restrito. p.70-73Cephalic allodynia (CA) can be observed in 50-70% of patient...
OnabotulinumtoxinA (BT-A) is one of the few drugs approved for the preventive treatment of chronic m...
Refractory chronic migraine is a disabling disorder impacting quality of life. BOTOX® (Onabotuli...
Neck disability and pain are frequently encountered problems in patients with chronic migraine (CM)....
Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity o...
Migraine is a common primary headache disease, which reduces quality of life. About 8% of migraineur...
Recent trials have demonstrated that onabotulinumtoxinA is a safe and effective treatment for the pr...
Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the possible eff...
Background: Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the ...
Chronic migraine (CM) is a severely disabling neurological condition characterized by episodes of pu...
Migraine is a highly prevalent and disabling disorder accounted among the primary headaches. It is t...
Cephalic allodynia (CA) can be observed in 50-70% of patients with chronic migraine (CM). The aim of...
Chronic migraine is a debilitating headache, whose treatment is often complicated by the concomitant...
Recent studies demonstrating the effectiveness of botulinum toxin type A (BT-a) in treating several ...
Abstract: Objective : The Botulinum toxin A (BoNT/A), increasingly used in many fields in recent yea...
Texto completo: acesso restrito. p.70-73Cephalic allodynia (CA) can be observed in 50-70% of patient...
OnabotulinumtoxinA (BT-A) is one of the few drugs approved for the preventive treatment of chronic m...
Refractory chronic migraine is a disabling disorder impacting quality of life. BOTOX® (Onabotuli...
Neck disability and pain are frequently encountered problems in patients with chronic migraine (CM)....
Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity o...
Migraine is a common primary headache disease, which reduces quality of life. About 8% of migraineur...
Recent trials have demonstrated that onabotulinumtoxinA is a safe and effective treatment for the pr...
DOI
Add to ORKG